The Benefits of Superficial Radiotherapy (SRT)
Non-melanoma skin cancer is one of the most common types of skin cancer, with millions of new cases reported each year. While there are various treatment options available, one of the most effective and widely used methods is superficial radiotherapy (SRT). What is Superficial Radiotherapy? Superficial radiotherapy is a type of external radiotherapy that targets […]
Basal cell carcinoma versus squamous cell carcinoma
You may have heard about two types of non-melanoma skin cancer: basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). While both are common forms of non-melanoma skin cancer, they differ in their risk factors, appearance and treatment options. So, let’s explore some of the differences between basal cell carcinoma versus squamous cell carcinoma. Basal […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions Introduces recurring revenue model for the SRT-100 Vision™ (IG-SRT) to address dermatologist demand Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 08, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions Introduces recurring revenue model for the SRT-100 Vision™ (IG-SRT) to address dermatologist demand Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 08, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing […]
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
BOCA RATON, Fla., Feb. 08, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued Patent No. 11,894,123 B2, titled “Radiotherapy Mobile and Wireless Device Workflow Management System.” This […]
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
BOCA RATON, Fla., Feb. 08, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued Patent No. 11,894,123 B2, titled “Radiotherapy Mobile and Wireless Device Workflow Management System.” This […]
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammatory diseases BOCA RATON, Fla., Feb. 06, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces a new multi-faceted collaboration with […]
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammatory diseases BOCA RATON, Fla., Feb. 06, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces a new multi-faceted collaboration with […]
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
BOCA RATON, Fla., Feb. 01, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O’Rear will not stand for reelection to the Company’s Board of Directors at the Company’s 2024 annual meeting of stockholders. Mr. O’Rear […]
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
BOCA RATON, Fla., Feb. 01, 2024 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O’Rear will not stand for reelection to the Company’s Board of Directors at the Company’s 2024 annual meeting of stockholders. Mr. O’Rear […]
